阳性症状

  • 网络PANSS-P;Positive Symptom;SAPS
阳性症状阳性症状
  1. 阴性症状组的双侧脑室前角距/颅内板距比(BFR)较阳性症状组为大。

    The bifrontal ratio ( BFR ) score in negative symptoms group was larger than that in positive symptoms group .

  2. 采用阴性症状量表(SANS)和阳性症状量表(SAPS)评价患者的精神病性症状的疗效。

    The efficacy was measured by Scale for the Assessment of Negative Symptoms ( SANS ) and Scale for Assessment of Positive Symptoms ( SAPS ) .

  3. C组参演学员的心理阳性症状、焦虑、抑郁评分较其他两组都高。

    Subjects in group C had more positive mental symptoms and higher scores of depression and anxiety than subjects in the other 2 groups .

  4. 结果:阳性症状精神分裂症患者血清一氧化氮明显高于正常组(P<0.01),阴性症状精神分裂症患者血清一氧化氮含量明显低于正常组(P<0.01)。

    Results : The serum nitric oxide level of type ⅰ schizophrenia was significantly higher , while type ⅱ lower than normal controls ( both P < 0 01 ) .

  5. 方法对60例脑震荡患者进行90项症状自评量表(SCL-90)评定,并与常模(正常人阳性症状均分)比较。

    Methods 60 cases of brain concussion were tested by Symptom Check-List 90 ( SCL-90 ), then compared with the normal .

  6. 目的:探讨Ⅰ、Ⅱ型精神分裂症患者事件相关电位P300的特点及事件相关电位与阴性、阳性症状的相关性。

    Objective : To explore the features of the Event-related potential P300 in patients with schizophrenics of type ⅰ and ⅱ .

  7. 阴性症状组患者IL-6水平明显高于阳性症状组和正常对照组,而其IL-10水平则低于阳性症状组;

    IL-6 was significantly higher in negative symptom subgroup compared with positive subgroup and controls , while IL-10 was lower in negative subgroup than in positive ones .

  8. 精神分裂症患者的虚假记忆指标与PANSS总分、阴性症状、阳性症状以及妄想症状、幻觉症状无显著相关性。

    The indexes of false memory had no significant correlation to the factors of delusion and hallucination of PANSS .

  9. 目的:研究以阴性、阳性症状为主的精神分裂症患者的事件相关电位(ERPs)。

    Objective : To study the event related potentials ( EPRs ) differences between negative and positive drug free schizophrenia .

  10. 所有阳性症状均在20min内消失。

    All the symptoms disappeared within 20 min.

  11. 采用阳性症状和阴性症状量表(PANSS)评定临床疗效,不良反应量表(TESS)评定不良反应。

    The positive and negative syndrome scale ( PANSS ) and treatment emergent symptoms scale ( TESS ) were used to evaluate curative effect and untoward reaction .

  12. 结论精神分裂症患者发病期血清CPK活性明显增高,而阴性症状为主要症状的患者和阳性症状为主要症状的患者间存在差异性;

    Conclusion The activity of serum CPK increases clearly during onset period in schizophrenics , and there was a difference between patients with positive and negative symptoms ;

  13. 两组均以阴性症状量表(SANS)、阳性症状量表(SAPS)、简明精神病症状量表(BPRS)和副反应量表(TESS)进行盲式评分。

    Both were double-blindly assessed with the SAPS , SANS , BPRS and TESS , before and after treatment , to evaluate the effects on positive and negative symptoms .

  14. 目的探讨具有暴力行为的分裂症患者阳性症状、阴性症状评定量表(PANSS)的相关特征,为预防减少分裂症患者暴力行为提供依据。

    Objective To explore the relation character of schizophrenics with an act of violence in PANSS evaluation and afford a foundation for decreasing the violence of schizophrenics .

  15. N2潜伏期和波幅与PANSS阳性症状分呈负相关,而WCST总错误数与PANSS总分和阴性症状总分正相关。

    Latency and amplitude of N2 negatively correlated with scores for positive symptoms , total errors in WCST positively related with PANSS total scores and scores for negative symptoms .

  16. 对照组出现兴奋激越的例数明显多于研究组(p0.05),其他副作用差异无显著性。(5)相关分析结果显示:患者的阳性症状、一般病理症状和各项认知测验结果均无相关性。

    Patients in the matched group who had excited agitation were more than patients in the controlled group ( p0.05 ), other side effects were no significant difference . ( 5 ) Correlation analysis showed : The positive symptoms and additional symptoms were not correlated with the cognitive test .

  17. 结论:精神分裂症患者在发病期的CPK活性显著升高,与病情关系密切,与阳性症状相平行,这可能是精神分裂症的神经内分泌免疫、代谢相互作用的结果。

    Conclusion : In onset period of schizophrenia , the serum CPK levels increased significantly and were closely correlated with positive symptoms . This may be the result of the interaction among neuroendocrine , immunity and metabolism .

  18. 结果随访结束时,观察组PANSS总分、阳性症状及阴性症状评分显著低于对照组(均P0·01);

    Results At the end of follow-up , the scores of the total PANSS , positive symptoms and negative symptoms in the observation group were significantly lower than those in the control group ( all P0.01 ) .

  19. 结果:合用组治疗2周后PANSS量表总分、阳性症状分、精神病理因子分及症状群中激活性、偏执、攻击性分值均显著下降;

    Results : In the group treated with risperidone combined with clonazepam injection after a 2 week treatment , scores of total PANSS , negative symptoms , psychopathology , irritability , paranoid , aggressiveness significantly decreased .

  20. 其IL6水平与患者的阴性症状分呈正相关,与阳性症状分呈负相关,与疾病的严重程度无明显相关。

    Interleukin 6 levels in FS patients were positively related to the scores of negative symptoms , and negatively to the positive symptoms , whereas not related to the total PANSS scores .

  21. 结果:两组患者治疗前PANSS总分、阳性症状分、阴性症状分及一般精神病理分、TESS总分比较,差异无显著性(P>0.05);

    RESULTS : The scores of pretreatment PANSS , PANSS P ( positive scale ), PANSS N ( negative scale ), PANSS G ( general psychopathology scale ) and total TESS were not significantly different between treatment and control groups ( P > 0.05 ) .

  22. 阳性症状和阴性症状两类精神分裂症亚型分别与健康对照组相比,或两个亚型间比较,同样在DAT1基因多态性分布上无差异(Z值小于1.96,P>0.05)。

    There were no significant differences in the distributions between the positive symptom group or the negative symptom group and the healthy controls , neither between the positive group and the negative group ( Z < 1.96 , P > 0.05 ) .

  23. 阴性者加入Valsalvas动作后阳性症状出现率增加17.39%(P<0.05),与对照组比较检出率有显著性差异(P<0.01)。

    The positive percentage of dizziness symptoms in trail group was 36.9 % and raise 17.36 % ( P < 0.05 ) after the addition of Valsalva 's. There was a significant difference compared with the normal control ( P < 0.01 ) .

  24. 用简明精神病评定量表(BPRS)、阴性症状评定量表(SANS)、阳性症状评定量表(SAPS)、威斯康星卡片分类测验(WCST)进行评定。

    The clinical symptoms were assessed using Brief Psychiatric Rating Scale ( BPRS ), Scale for Assessment of Negative Symptom ( SANS ), Scale for Assessment of Positive Symptom ( SAPS ), Wisconsin Card Sorting Test ( WCST ) at pre and post treatment .

  25. 方法:对符合CCMD-2-R诊断标准的精神分裂症50例住院患者的症状,用阳性症状和阴性症状量表(PANSS)进行评定,并对阴性症状和抑郁症状作多因素相关分析。

    Method : 50 inpatients who met CCMD 2 R criteria for schizophrenia were involved in this study . Positive and negative symptom scale ( PANSS ) was used to assess symptoms . Multivariable correlation analysis was performed to explain relationship between negative symptoms and depression in schizophrenia .

  26. 结果:精神分裂症阳性症状患者5-HT2A受体基因型频率、等位基因频率与对照组无明显差异,但有精神病家族史精神分裂症患者A1A1基因型频率,A1等位基因频率明显高于对照组。

    Results : The frequencies of A 1A 1 genetype and A 1 allele were higher in schizophrenia with positive history than in controls . No differences were found in the frequencies of 5-HT 2A receptor genetype and allele gene between two groups .

  27. 目的:验证利培酮对精神分裂症阳性症状的疗效。

    To estimate the effect of risperidone treatment schizophrenic positive symptom .

  28. 唾液地塞米松抑制试验与精神分裂症患者阴性、阳性症状

    Salivary dexamethasone suppression test and positive and negative symptoms in schizophrenia

  29. 阴性及阳性症状为主型精神分裂症患者脑功能网络分析

    A Functional Network Analysis in Schizophrenics with Negative and Positive Symptoms

  30. 精神分裂症阴、阳性症状的因子结构

    The factor structure in schizophrenia with negative and positive symptoms